Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line For The Management of Rheumatoid Arthritis In Greece
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1111
https://www.valueinhealthjournal.com/article/S1098-3015(16)32477-9/fulltext
Title :
Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line For The Management of Rheumatoid Arthritis In Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32477-9&doi=10.1016/j.jval.2016.09.1111
First page :
A538
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1040